Data from multiple sources - Curated by Toby Galbraith - Last updated 04 April 2017

Focus on melanomas of skin

Although it is one of the rarer forms of skin cancer, melanoma is responsible for a disproportionate amount of mortality. Its incidence has been increasing over time, and is heavily linked to sun exposure. Figures from the World Health Organization suggest an annual incidence of 132,000 worldwide.

Read more on Melanomas of skin

 

Latest news articles

Added 1 month ago Drug news

Array BioPharma Inc.,withdraws from the FDA, binimetinib monotherapy for the treatment of NRAS-mutant melanoma.

Array BioPharma Inc. announced that it has withdrawn from the FDA Division of Oncology Products its new drug application (NDA)...

Added 8 months ago Drug news

UK NICE U-turn now recommends Imlygic (talimogene laherparepvec) for unresectable, regionally or distantly metastatic (Stage IIIB, IIIC or IVM1a) melanoma- Amgen

NICE has issued final guidance overturning its earlier recommendation, and now endorsing Imlygic (talimogene laherparepvec), from Amgen, as an option...

Added 9 months ago Drug news

Study of Chemosat (melphalan for injection) shows survival benefit in metastatic uveal melanoma patients- Delcath Systems

Delcath Systems has announced that data from a large single hospital experience of Chemosat (melphalan for injection) conducted at Southampton...

View all news articles

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Obstructive Pulmonary Disease (COPD)

View highlights from recent congresses presented in new expert videos with leading physicians

Visit Chronic Obstructive Pulmonary Disease (COPD)

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

Visit Chronic Spontaneous Urticaria (CSU)

Guidelines

Melanoma: assessment and management

This guideline covers the assessment and management of melanoma (a type of skin cancer) in children, young people and adults....

Added July 2015 ago

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cutaneous melanoma is the most common type of melanoma, and UV exposure is one of the main risk factors. The...

Added July 2015 ago

View all guidelines

Journal articles

Pembrolizumab use for the treatment of advanced melanoma.

Introduction: Until recently, overall long term survival in patients with stage IV melanoma was lower than 10 %. However, the treatment of melanoma has evolved rapidly over the last few years ...

Added March 2017 ago

Risk of cumulative toxicity after complete melanoma response with pembrolizumab.

Pembrolizumab is an approved first-line systemic therapy for unresectable metastatic melanoma. Despite the achievement of complete and durable responses in a small subgroup of patients, it is standard practice that ...

Added March 2017 ago

Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor.

Targeted immunotherapy has become the most promising approach for tumor patients. Programmed death-1 (PD-1), an inhibitory receptor expressed on activated T cells, can reverse immune suppression and release T cell activation.

Added March 2017 ago

View all journal articles

CME

Urgent referrals in dermatology

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0

Malignant melanoma: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
2
Registration required
1
Subscription fee
0

Test your knowledge of recent NICE guidance

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0
View all CME